| III-45 Matts Kågedal Herceptin in HER2-positive Gastric Cancer: Evaluation of Exposure-Response with Two Dose Levels. Thursday 09:50-11:20 |
| III-45 Matts Kågedal Herceptin in HER2-positive Gastric Cancer: Evaluation of Exposure-Response with Two Dose Levels. Thursday 09:50-11:20 |